Viral Vectors-Based Gene Therapy for Non-Human Primates to Account for a Market Share of Over US$ 92.76 Million by 2034, Growing at a 11.0% CAGR, Latest Report by TMR

The global viral vectors-based gene therapy market for non-human primates is set for substantial growth, driven by advancements in gene therapy and rising demand for preclinical studies. The integration of innovative technologies like AAV vectors and CRISPR gene editing is enhancing gene delivery precisionWilmington, Delaware, Transparency Market Research Inc. –, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Viral Vectors-Based Gene Therapy for Non-Human Primates Market Outlook – Accelerating Growth and Future Prospect ...